BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today ...

Millicom International Cellular S.A. (NASDAQ: TIGO), a leading telecommunications provider in Latin America, reported first quarter 2025 revenue that fel ...

Rachid Meziane finished up another practice Wednesday, neither overjoyed nor overly concerned. This is going to be a process, to make the kind of basketball he knows ...

Three former Memphis officers were acquitted Wednesday of state charges, including second-degree murder, in the fatal beating ...

Getting a larger share of a business that you like is always something that you would take a look at,” he said. “We have ...

Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPPP ...

The Herald Review, is collaborating with First Call for Help, the Crisis Response Team, Itasca County Health and Human Services, and the Itasca County Sheriff’s Office to help educate, inform, ...

Initiated APOLLO, a double-blind, placebo-controlled, confirmatory trial of bitopertin in adults and adolescents with EPP.

In the wake of the Vietnam War, savvy Vietnamese entrepreneurs used their tight-knit communities and social capital to radically reshape the salon industry.

A North West-headquartered chemicals manufacturing business which was established about 180 years ago has been acquired by H2 Equity Partners in a carve-out deal.

Synthomer Plc (London, U.K.) announced an agreement to divest William Blythe Ltd., its inorganic chemistry business, to its management team alongside H2 ...

(Sharecast News) - Chemicals business Synthomer has agreed to divest William Blythe, its inorganic chemistry business, to its management team and H2 E... (Alliance News) - The following is a round-up ...